Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Forbes Medi-Tech Announces Next Steps in Pharmaceutical Development and Corporate Restructuring; Company Eliminates Non-Core R&D Expenses and Extends Working Capital to Mid 2008.
- VANCOUVER, BRITISH COLUMBIA, Feb 12, 2007 CCNMatthews via COMTEX -- Forbes Medi-Tech Inc. (TSX:FMI)(NASDAQ:FMTI) today announced the next steps for its pharmaceutical development program and restructuring measures in R&D to extend the Company's VANCOUVER, BRITISH COLUMBIA, Feb 12, 2007 CCNMatthews via COMTEX -- Forbes Medi-Tech...
- Research articles 2007-02-12
- EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist™ Approvable Letters; Company Remains Committed To Making Novel Blood-Pool Imaging Agent Available in U.S
- CAMBRIDGE, Mass. -- EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a developer of innovative pharmaceuticals for magnetic resonance imaging MRI which recently announced a definitive agreement to merge with Predix Pharmaceuticals Holdings, Inc., today announced that it has submitted a formal appeal to the U.S. Food and Drug Administration FDA asking the...
- Research articles 2006-06-30
- European specialty players revamp and replace their strategy. (Focus 2003: Specialty Chemicals/ChemSpec Europe Preview).
- Threatened with commoditization, companies take drastic measures, not only cutting costs and divesting operations, but also seeking an entirely different, closer relationship with their customers. Under pressure from sluggish demand, difficult Threatened with commoditization, companies take drastic measures, ...
- Research articles 2003-04-28
- Forbes Medi-Tech Announces Next Steps in Pharmaceutical Development and Corporate Restructuring
- Forbes Medi-Tech Inc. (TSX: FMI)(NASDAQ: FMTI) today announced the next steps for its pharmaceutical development program and restructuring measures in R&D to extend the Company's working capital and optimize the Company's remaining capital resources. Based on the results from the recently completed US Phase II trial, the Company's immediate pharmaceutical...
- Research articles 2007-02-12
- NOVARTIS' EXPANSION CONTINUES IN CHINA
- AsiaInfo Services 03-20-2007 Novartis' Expansion Continues in China BEIJING, Mar 20, 2007 SinoCast via COMTEX -- Novartis AG, the world's fourth-largest pharmaceutical company, plans to invest more in research and development of the Chinese h AsiaInfo Services ...
- Research articles 2007-03-20
- Pfizer-Pharmacia fallout could be Rx for small firms.(laid-off scientists could fill slots at smaller new companies)(Brief Article)
- Historically, mergers of big pharmaceutical companies in Michigan have given life to small biotechnology companies when disgruntled or laid-off scientists left. Experts say Pfizer Inc.'s acquisition of Pharmacia Corp. is likely no exception. The h Historically, mergers of big pharmaceutical companies in Michigan...
- Research articles 2002-07-29
- DENTSPLY International Inc. Provides Pharmaceutical Business Update
- YORK, Pa. -- DENTSPLY International Inc. (NASDAQ:XRAY) today announced that, as a result of its continuing evaluation of the dental injectable anesthetic business, the Company will close its Chicago-based Pharmaceutical Manufacturing facility. The Company plans to sell the facility and to seek third party sources of supply for the dental...
- Research articles 2006-02-08
- Axcan Pharma to Present at the Credit Suisse Annual Healthcare Conference.(Conference news)
- MONT-SAINT-HILAIRE, QUEBEC, Nov 7, 2007 Marketwire via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Tuesday, November 13, 2007, Senior Vice President and Chief Financial O MONT-SAINT-HILAIRE, QUEBEC, Nov 7, 2007 Marketwire via COMTEX -- Axcan Pharma Inc. ("Axcan"...
- Research articles 2007-11-07
- Axcan Pharma to Present at the UBS Global Life Sciences Conference.(Conference news)
- MONT-SAINT-HILAIRE, QUEBEC, Sep 19, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, September 26, 2007, President and Chief Executive Officer, MONT-SAINT-HILAIRE, QUEBEC, Sep 19, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the...
- Research articles 2007-09-19
- Rx for big property risks; Pharmaceuticals set up mutual insurer.(News)(Pharmaceutical Insurance Ltd. is formed)
- Byline: RODD ZOLKOS HAMILTON, Bermuda-The formation by seven major pharmaceutical companies of a Bermuda-based mutual insurance company to provide excess property and business interruption coverage signals a trend, some say, toward companies with Byline: RODD ZOLKOS HAMILTON, Bermuda-The formation...
- Research articles 2003-06-02
- APP Pharmaceuticals Receives Letter Regarding Nasdaq Rule 4350
- SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today said it received a letter from The Nasdaq Stock Market, Inc. indicating that the Company was no longer in compliance with Nasdaq's Marketplace Rule 4350d(2). This rule requires the Company to have...
- Research articles 2007-12-18
- Drugmaker ready for outbreak.(Spotlight: RIMS 2007 Trends & Developments)(F. Hoffmann-La Roche Ltd. preparations for a deadly pandemic)(Brief article)
- Byline: Gloria Gonzalez Being the manufacturer of the No. 1 prescribed influenza medication has put pharmaceutical company F. Hoffmann-La Roche Ltd. at the forefront of preparations for a potentially deadly pandemic. As part of its pandemic prep Byline: Gloria Gonzalez ...
- Research articles 2007-05-14
- Arrowhead Streamlines Business Model of Nanobiotech Subs, Calando Pharmaceuticals and Insert Therapeutics
- PASADENA, Calif. -- Arrowhead Research Corporation (Nasdaq:ARWR) announced today a fundamental streamlining of its majority-owned subsidiaries, Calando Pharmaceuticals and Insert Therapeutics. Arrowhead will assume active management of the companies and focus resources on bringing multiple products to the clinic as rapidly as possible. Arrowhead's expanded role is intended to make...
- Research articles 2008-02-28
- Axcan to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference.
- MONT-SAINT-HILAIRE, QUEBEC, Jan 31, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Tuesday, February 6, 2007, President and Chief Executive Officer, Fra MONT-SAINT-HILAIRE, QUEBEC, Jan 31, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or...
- Research articles 2007-01-31
- Axcan Pharma to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, UK.(Conference news)
- MONT-SAINT-HILAIRE, QUEBEC, Sep 14, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Tuesday, September 18, 2007, President and Chief Executive Officer, F MONT-SAINT-HILAIRE, QUEBEC, Sep 14, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or...
- Research articles 2007-09-14
- Axcan Pharma to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference.
- MONT-SAINT-HILAIRE, QUEBEC, May 2, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Tuesday, May 8, 2007, Senior Vice President and Chief Financial Office MONT-SAINT-HILAIRE, QUEBEC, May 2, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan"...
- Research articles 2007-05-02
- Aventis Pharma to invest US$76mil in Brazil.
- Aventis Pharma plans to invest US$76.5mil in Brazil over the next 3 years. The company holds nearly 5.7% of the Brazilian prescription drugs market, which generated sales of US$556mil in 1998. In order to produce a new world drug, the company is ...
- Research articles 2000-01-26
- Battle Over Warner-Lambert Could Fuel Consolidations.
- European firms may be at a disadvantage in R&D spending. THE TAKEOVER BATTLE between Pfizer Inc. and Warner-Lambert Company is forcing European drug manufacturers to reevaluate their positions in the global pharmaceutical industry. Analyst European firms may be at...
- Research articles 1999-11-29
- Axcan to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, UK.
- MONT SAINT-HILAIRE, QUEBEC, Sep 18, 2006 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX VENTURE:AXP) (Nasdaq:AXCA) today announced that on Thursday, September 21, 2006, President and Chief Executive MONT SAINT-HILAIRE, QUEBEC, Sep 18, 2006 CCNMatthews via COMTEX -- Axcan Pharma...
- Research articles 2006-09-18
- Researchers move to Internet for lab supplies.(Brief Article)
- Researchers in the chemical and pharmaceutical industries are busy people working under tight deadlines. In addition to the many scientific challenges they face, these researchers are often responsible for procuring their own beakers, Bunsen burner Researchers in the chemical and pharmaceutical industries are busy...
- Research articles 2000-03-23
- << Previous
- page 1 of 4
- Next >>
Refining Tags
- sales (12 results)
- Merck & Co. Inc. (8 results)
- biotechnology (7 results)
- Aventis (6 results)
- Pfizer Inc. (6 results)
- BASF AG (5 results)
- chemicals (4 results)
- manufacturing (4 results)
- merger (4 results)
- life science (4 results)
- R&D (4 results)
- AstraZeneca Plc. (3 results)
- technology (3 results)
- health care (3 results)
- Rhodia (3 results)
- Roche Holding AG (3 results)
- Merrill Lynch & Co. Inc. (3 results)
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
